RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Integra Lifesciences Holdings Stock

Integra Lifesciences Holdings Stocks 2024

Integra Lifesciences Holdings Stocks

80.34 M

Ticker

IART

ISIN

US4579852082

WKN

897013

In 2024, Integra Lifesciences Holdings had 80.34 M outstanding stocks, a 0% change from the 80.34 M stocks in the previous year.

The Integra Lifesciences Holdings Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2027e80.34
2026e80.34
2025e80.34
2024e80.34
202380.34
202283.5
202185.5
202085.2
201986.5
201884
201779.1
201679.2
201569
201465.9
201356.8
201257
201159
201060.3
200958.6
200856.8
200758.7
200665.5
200569.1
200462.2

Integra Lifesciences Holdings shares outstanding

The number of shares was Integra Lifesciences Holdings in 2023 — This indicates how many shares 80.337 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Integra Lifesciences Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Integra Lifesciences Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Integra Lifesciences Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Integra Lifesciences Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Integra Lifesciences Holdings Aktienanalyse

What does Integra Lifesciences Holdings do?

Integra Lifesciences Holdings Corp is a multinational manufacturer and provider of medical devices, implants, and instruments. The company is headquartered in Plainsboro, New Jersey and was founded in 1989. Integra Lifesciences specializes in the development and marketing of products for orthopedic surgery, neurosurgery, and plastic and reconstructive surgery. The company has a wide range of products that have been constantly improved and expanded over the years. The history of Integra Lifesciences is characterized by continuous expansion through the acquisition of other companies. In 1996, the company acquired Confluent Surgical, which allowed them to enter the tissue adhesive sector. In the following years, several companies were acquired, including Depuy Orthopaedics, Kaye Surgical, and SeaSpine Holdings. Each acquisition has contributed to Integra Lifesciences being able to offer its customers an extensive product portfolio that meets all requirements. Integra Lifesciences has a diversified business model that focuses on four different divisions: anesthesia, neurosurgery, plastic and reconstructive surgery, and orthopedic surgery. Each division has its own range of products that are tailored to the specific requirements of its customers. Integra Lifesciences supplies high-quality medical instruments that are valued by surgeons around the world. These include products such as bone cement, implants, skull plates, bone screws, tissue adhesives, and spinal fusion devices. All products from Integra Lifesciences aim to improve patient care and enhance patients' quality of life. The anesthesia division offers a wide range of products and technologies that improve the administration of anesthesia and enable optimal patient care. In addition to traditional products such as anesthesia masks and tubes, Integra Lifesciences also develops innovative products such as disposable ventilation systems that can increase safety and efficiency. The neurosurgery division offers a wide range of devices and implants for the treatment of brain and spinal cord conditions. The product range includes skull plates, bone connectors, and devices for performing brain surgeries. In the plastic and reconstructive surgery division, Integra Lifesciences offers products for the treatment of burns and the reconstruction of bones and soft tissues. The company has a wide range of products, including skin grafts, scar treatment, and liposuction. Orthopedic surgery is one of the established divisions at Integra Lifesciences, offering a wide range of products for the treatment of bone and joint problems. The company provides implants and instruments for all types of orthopedic procedures, including hip and knee replacements, spinal fusion, and limb reconstruction. Overall, Integra Lifesciences Holdings Corp is a leading manufacturer of medical devices, implants, and instruments specializing in the fields of orthopedics, neurosurgery, and plastic and reconstructive surgery. With its comprehensive product range and innovative technologies, Integra Lifesciences has gained a leading position in the industry, providing its customers worldwide with the highest quality and safety. Integra Lifesciences Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Integra Lifesciences Holdings's Shares Outstanding

Integra Lifesciences Holdings's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Integra Lifesciences Holdings’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Integra Lifesciences Holdings’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Integra Lifesciences Holdings’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Integra Lifesciences Holdings stock

How many stocks are there of Integra Lifesciences Holdings?

The current number of stocks of Integra Lifesciences Holdings is 80.34 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Integra Lifesciences Holdings are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Integra Lifesciences Holdings evolved in recent years?

The number of shares of Integra Lifesciences Holdings has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Integra Lifesciences Holdings as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Integra Lifesciences Holdings?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Integra Lifesciences Holdings pay?

Over the past 12 months, Integra Lifesciences Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Integra Lifesciences Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Integra Lifesciences Holdings?

The current dividend yield of Integra Lifesciences Holdings is .

When does Integra Lifesciences Holdings pay dividends?

Integra Lifesciences Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Integra Lifesciences Holdings?

Integra Lifesciences Holdings paid dividends every year for the past 0 years.

What is the dividend of Integra Lifesciences Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Integra Lifesciences Holdings located?

Integra Lifesciences Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Integra Lifesciences Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Integra Lifesciences Holdings from 9/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Integra Lifesciences Holdings pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Integra Lifesciences Holdings in the year 2023?

In the year 2023, Integra Lifesciences Holdings distributed 0 USD as dividends.

In which currency does Integra Lifesciences Holdings pay out the dividend?

The dividends of Integra Lifesciences Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Integra Lifesciences Holdings

Our stock analysis for Integra Lifesciences Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Integra Lifesciences Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.